Desai, M. Y.; Department of Cardiovascular Medicine, Center for Radiation Heart Disease, Heart and Vascular Institute, Cleveland Clinic, Cleveland, OH, United States
Windecker, S.; Department of Cardiology, Inselspital, University of Bern, Bern, Switzerland
Lancellotti, Patrizio ; Université de Liège - ULiège > Département des sciences cliniques > Cardiologie - Pathologie spéciale et réhabilitation
Bax, J. J.; Department of Cardiology, University of Leiden, Netherlands
Griffin, B. P.; Department of Cardiovascular Medicine, Center for Radiation Heart Disease, Heart and Vascular Institute, Cleveland Clinic, Cleveland, OH, United States
Cahlon, O.; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, United States
Johnston, D. R.; Department of Cardiothoracic Surgery, Center for Radiation Heart Disease, Heart and Vascular Institute, Cleveland Clinic, Cleveland, OH, United States
Language :
English
Title :
Prevention, Diagnosis, and Management of Radiation-Associated Cardiac Disease: JACC Scientific Expert Panel
van Nimwegen, F.A., Ntentas, G., Darby, S.C., et al. Risk of heart failure in survivors of Hodgkin lymphoma: effects of cardiac exposure to radiation and anthracyclines. Blood 129 (2017), 2257–2265.
Saiki, H., Petersen, I.A., Scott, C.G., et al. Risk of heart failure with preserved ejection fraction in older women after contemporary radiotherapy for breast cancer. Circulation 135 (2017), 1388–1396.
Cutter, D.J., Schaapveld, M., Darby, S.C., et al. Risk of valvular heart disease after treatment for Hodgkin lymphoma. J Natl Cancer Inst, 107, 2015, djv008.
van Nimwegen, F.A., Schaapveld, M., Cutter, D.J., et al. Radiation dose-response relationship for risk of coronary heart disease in survivors of Hodgkin lymphoma. J Clin Oncol 34 (2016), 235–243.
Darby, S.C., Ewertz, M., McGale, P., et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med 368 (2013), 987–998.
van Nimwegen, F.A., Schaapveld, M., Janus, C.P., et al. Cardiovascular disease after Hodgkin lymphoma treatment: 40-year disease risk. JAMA Intern Med 175 (2015), 1007–1017.
McGale, P., Darby, S.C., Hall, P., et al. Incidence of heart disease in 35,000 women treated with radiotherapy for breast cancer in Denmark and Sweden. Radiother Oncol 100 (2011), 167–175.
Sardar, P., Kundu, A., Chatterjee, S., et al. Long-term cardiovascular mortality after radiotherapy for breast cancer: a systematic review and meta-analysis. Clin Cardiol 40 (2017), 73–81.
Rehammar, J.C., Jensen, M.B., McGale, P., et al. Risk of heart disease in relation to radiotherapy and chemotherapy with anthracyclines among 19,464 breast cancer patients in Denmark, 1977-2005. Radiother Oncol 123 (2017), 299–305.
Groarke, J.D., Tanguturi, V.K., Hainer, J., et al. Abnormal exercise response in long-term survivors of Hodgkin lymphoma treated with thoracic irradiation: evidence of cardiac autonomic dysfunction and impact on outcomes. J Am Coll Cardiol 65 (2015), 573–583.
Carmel, R.J., Kaplan, H.S., Mantle irradiation in Hodgkin's disease. An analysis of technique, tumor eradication, and complications. Cancer 37 (1976), 2813–2825.
Fukada, J., Shigematsu, N., Takeuchi, H., et al. Symptomatic pericardial effusion after chemoradiation therapy in esophageal cancer patients. Int J Radiat Oncol Biol Phys 87 (2013), 487–493.
Leon, M.B., Smith, C.R., Mack, M., et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 363 (2010), 1597–1607.
Horning, S.J., Adhikari, A., Rizk, N., et al. Effect of treatment for Hodgkin's disease on pulmonary function: results of a prospective study. J Clin Oncol 12 (1994), 297–305.
Maraldo, M.V., Brodin, N.P., Vogelius, I.R., et al. Risk of developing cardiovascular disease after involved node radiotherapy versus mantle field for Hodgkin lymphoma. Int J Radiat Oncol Biol Phys 83 (2012), 1232–1237.
Specht, L., Yahalom, J., Illidge, T., et al. Modern radiation therapy for Hodgkin lymphoma: field and dose guidelines from the international lymphoma radiation oncology group (ILROG). Int J Radiat Oncol Biol Phys 89 (2014), 854–862.
Straus, D.J., Johnson, J.L., LaCasce, A.S., et al. Doxorubicin, vinblastine, and gemcitabine (CALGB 50203) for stage I/II nonbulky Hodgkin lymphoma: pretreatment prognostic factors and interim PET. Blood 117 (2011), 5314–5320.
Petersen, P.M., Aznar, M.C., Berthelsen, A.K., et al. Prospective phase II trial of image-guided radiotherapy in Hodgkin lymphoma: benefit of deep inspiration breath-hold. Acta Oncol 54 (2015), 60–66.
Hoppe, B.S., Flampouri, S., Su, Z., et al. Effective dose reduction to cardiac structures using protons compared with 3DCRT and IMRT in mediastinal Hodgkin lymphoma. Int J Radiat Oncol Biol Phys 84 (2012), 449–455.
Maraldo, M.V., Dabaja, B.S., Filippi, A.R., et al. Radiation therapy planning for early-stage Hodgkin lymphoma: experience of the International Lymphoma Radiation Oncology Group. Int J Radiat Oncol Biol Phys 92 (2015), 144–152.
Dabaja, B.S., Hoppe, B.S., Plastaras, J.P., et al. Proton therapy for adults with mediastinal lymphomas: the International Lymphoma Radiation Oncology Group guidelines. Blood 132 (2018), 1635–1646.
Darby, S., McGale, P., Correa, C., et al. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet 378 (2011), 1707–1716.
Nilsson, G., Holmberg, L., Garmo, H., et al. Distribution of coronary artery stenosis after radiation for breast cancer. J Clin Oncol 30 (2012), 380–386.
Early Breast Cancer Trialists' Collaborative Group. Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials. Lancet 355 (2000), 1757–1770.
Drost, L., Yee, C., Lam, H., et al. A systematic review of heart dose in breast radiotherapy. Clin Breast Cancer 18 (2018), e819–e824.
Arthur, D.W., Arnfield, M.R., Warwicke, L.A., et al. Internal mammary node coverage: an investigation of presently accepted techniques. Int J Radiat Oncol Biol Phys 48 (2000), 139–146.
Taylor, C.W., Wang, Z., Macaulay, E., et al. Exposure of the heart in breast cancer radiation therapy: a systematic review of heart doses published during 2003 to 2013. Int J Radiat Oncol Biol Phys 93 (2015), 845–853.
Ceilley, E., Jagsi, R., Goldberg, S., et al. Radiotherapy for invasive breast cancer in North America and Europe: results of a survey. Int J Radiat Oncol Biol Phys 61 (2005), 365–373.
Poortmans, P.M., Collette, S., Kirkove, C., et al. Internal mammary and medial supraclavicular irradiation in breast cancer. N Engl J Med 373 (2015), 317–327.
Whelan, T.J., Olivotto, I.A., Parulekar, W.R., et al. Regional nodal irradiation in early-stage breast cancer. N Engl J Med 373 (2015), 307–316.
Jagsi, R., Moran, J., Marsh, R., et al. Evaluation of four techniques using intensity-modulated radiation therapy for comprehensive locoregional irradiation of breast cancer. Int J Radiat Oncol Biol Phys 78 (2010), 1594–1603.
MacDonald, S.M., Patel, S.A., Hickey, S., et al. Proton therapy for breast cancer after mastectomy: early outcomes of a prospective clinical trial. Int J Radiat Oncol Biol Phys 86 (2013), 484–490.
Patel, S.A., Lu, H.M., Nyamwanda, J.A., et al. Postmastectomy radiation therapy technique and cardiopulmonary sparing: a dosimetric comparative analysis between photons and protons with free breathing versus deep inspiration breath hold. Pract Radiat Oncol 7 (2017), e377–e384.
Ares, C., Khan, S., Macartain, A.M., et al. Postoperative proton radiotherapy for localized and locoregional breast cancer: potential for clinically relevant improvements?. Int J Radiat Oncol Biol Phys 76 (2010), 685–697.
Luo, L., Cuaron, J., Braunstein, L., et al. Early outcomes of breast cancer patients treated with post-mastectomy uniform scanning proton therapy. Radiother Oncol 132 (2019), 250–256.
Verma, V., Iftekaruddin, Z., Badar, N., et al. Proton beam radiotherapy as part of comprehensive regional nodal irradiation for locally advanced breast cancer. Radiother Oncol 123 (2017), 294–298.
PORT Meta-analysis Trialists Group. Postoperative radiotherapy in non-small-cell lung cancer: systematic review and meta-analysis of individual patient data from nine randomised controlled trials. Lancet 352 (1998), 257–263.
Bradley, J.D., Paulus, R., Komaki, R., et al. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study. Lancet Oncol 16 (2015), 187–199.
Chang, J.Y., Verma, V., Li, M., et al. Proton beam radiotherapy and concurrent chemotherapy for unresectable stage iii non-small cell lung cancer: final results of a phase 2 study. JAMA Oncol, 3, 2017, e172032.
Cahlon, O., Khan, A.J., Cardiac toxicity: the more we learn, the less we know. Int J Radiat Oncol Biol Phys 99 (2017), 1162–1165.
Desmouliere, A., Geinoz, A., Gabbiani, F., et al. Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J Cell Biol 122 (1993), 103–111.
Scott, J.M., Zabor, E.C., Schwitzer, E., et al. Efficacy of exercise therapy on cardiorespiratory fitness in patients with cancer: a systematic review and meta-analysis. J Clin Oncol 36 (2018), 2297–2305.
Velensek, V., Mazic, U., Krzisnik, C., et al. Cardiac damage after treatment of childhood cancer: a long-term follow-up. BMC Cancer, 8, 2008, 141.
Adamo, V., Ricciardi, G.R., Adamo, B., et al. The risk of toxicities from trastuzumab, alone or in combination, in an elderly breast cancer population. Oncology 86 (2014), 16–21.
Heidenreich, P.A., Hancock, S.L., Lee, B.K., et al. Asymptomatic cardiac disease following mediastinal irradiation. J Am Coll Cardiol 42 (2003), 743–749.
Desai, M.Y., Wu, W., Masri, A., et al. Increased aorto-mitral curtain thickness independently predicts mortality in patients with radiation-associated cardiac disease undergoing cardiac surgery. Ann Thorac Surg 97 (2014), 1348–1355.
Hancock, S.L., Tucker, M.A., Hoppe, R.T., Factors affecting late mortality from heart disease after treatment of Hodgkin's disease. JAMA 270 (1993), 1949–1955.
Daitoku, K., Fukui, K., Ichinoseki, I., et al. Radiotherapy-induced aortic valve disease associated with porcelain aorta. Jpn J Thorac Cardiovasc Surg 52 (2004), 349–352.
Larsen, R.L., Jakacki, R.I., Vetter, V.L., et al. Electrocardiographic changes and arrhythmias after cancer therapy in children and young adults. Am J Cardiol 70 (1992), 73–77.
Crestanello, J.A., McGregor, C.G., Danielson, G.K., et al. Mitral and tricuspid valve repair in patients with previous mediastinal radiation therapy. Ann Thorac Surg 78 (2004), 826–831 discussion 826–31.
Rehammar, J.C., Johansen, J.B., Jensen, M.B., et al. Risk of pacemaker or implantable cardioverter defibrillator after radiotherapy for early-stage breast cancer in Denmark, 1982-2005. Radiother Oncol 122 (2017), 60–65.
Adams, M.J., Lipsitz, S.R., Colan, S.D., et al. Cardiovascular status in long-term survivors of Hodgkin's disease treated with chest radiotherapy. J Clin Oncol 22 (2004), 3139–3148.
Desai, M.Y., Karunakaravel, K., Wu, W., et al. Pulmonary fibrosis on multidetector computed tomography and mortality in patients with radiation-associated cardiac disease undergoing cardiac surgery. J Thorac Cardiovasc Surg 148 (2014), 475–481.e3.
Wu, W., Masri, A., Popovic, Z.B., et al. Long-term survival of patients with radiation heart disease undergoing cardiac surgery: a cohort study. Circulation 127 (2013), 1476–1485.
Lancellotti, P., Nkomo, V.T., Badano, L.P., et al. Expert consensus for multi-modality imaging evaluation of cardiovascular complications of radiotherapy in adults: a report from the European Association of Cardiovascular Imaging and the American Society of Echocardiography. Eur Heart J Cardiovasc Imaging 14 (2013), 721–740.
Zamorano, J.L., Lancellotti, P., Rodriguez Munoz, D., et al. 2016 ESC position paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: the Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC). Eur Heart J 37 (2016), 2768–2801.
Nellessen, U., Zingel, M., Hecker, H., et al. Effects of radiation therapy on myocardial cell integrity and pump function: which role for cardiac biomarkers?. Chemotherapy 56 (2010), 147–152.
Marchesseau, S., Ho, J.X., Totman, J.J., Influence of the short-axis cine acquisition protocol on the cardiac function evaluation: a reproducibility study. Eur J Radiol Open 3 (2016), 60–66.
Plana, J.C., Galderisi, M., Barac, A., et al. Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 27 (2014), 911–939.
Thavendiranathan, P., Grant, A.D., Negishi, T., et al. Reproducibility of echocardiographic techniques for sequential assessment of left ventricular ejection fraction and volumes: application to patients undergoing cancer chemotherapy. J Am Coll Cardiol 61 (2013), 77–84.
Armstrong, G.T., Joshi, V.M., Ness, K.K., et al. Comprehensive echocardiographic detection of treatment-related cardiac dysfunction in adult survivors of childhood cancer: results from the St. Jude lifetime cohort study. J Am Coll Cardiol 65 (2015), 2511–2522.
Farsalinos, K.E., Daraban, A.M., Unlu, S., et al. Head-to-head comparison of global longitudinal strain measurements among nine different vendors: the EACVI/ASE Inter-Vendor Comparison Study. J Am Soc Echocardiogr 28 (2015), 1171–1181.e2.
Chirakarnjanakorn, S., Popovic, Z.B., Wu, W., et al. Impact of long-axis function on cardiac surgical outcomes in patients with radiation-associated heart disease. J Thorac Cardiovasc Surg 149 (2015), 1643–1651.e1–2.
Desai, M.Y., Jellis, C.L., Kotecha, R., et al. Radiation-associated cardiac disease: a practical approach to diagnosis and management. J Am Coll Cardiol Img 11 (2018), 1132–1149.
Otto, C.M., Kumbhani, D.J., Alexander, K.P., et al. 2017 ACC expert consensus decision pathway for transcatheter aortic valve replacement in the management of adults with aortic stenosis: a report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol 69 (2017), 1313–1346.
Kamdar, A.R., Meadows, T.A., Roselli, E.E., et al. Multidetector computed tomographic angiography in planning of reoperative cardiothoracic surgery. Ann Thorac Surg 85 (2008), 1239–1245.
Verhaert, D., Gabriel, R.S., Johnston, D., et al. The role of multimodality imaging in the management of pericardial disease. Circ Cardiovasc Imaging 3 (2010), 333–343.
Heidenreich, P.A., Schnittger, I., Strauss, H.W., et al. Screening for coronary artery disease after mediastinal irradiation for Hodgkin's disease. J Clin Oncol 25 (2007), 43–49.
Hardenbergh, P.H., Munley, M.T., Bentel, G.C., et al. Cardiac perfusion changes in patients treated for breast cancer with radiation therapy and doxorubicin: preliminary results. Int J Radiat Oncol Biol Phys 49 (2001), 1023–1028.
Cremer, P.C., Tariq, M.U., Karwa, A., et al. Quantitative assessment of pericardial delayed hyperenhancement predicts clinical improvement in patients with constrictive pericarditis treated with anti-inflammatory therapy. Circ Cardiovasc Imaging, 8, 2015, e003125.
van Son, J.A., Noyez, L., van Asten, W.N., Use of internal mammary artery in myocardial revascularization after mediastinal irradiation. J Thorac Cardiovasc Surg 104 (1992), 1539–1544.
Lancellotti, P., Suter, T.M., Lopez-Fernandez, T., et al. Cardio-oncology services: rationale, organization, and implementation: a report from the ESC Cardio-Oncology council. Eur Heart J 40 (2019), 1756–1763.
Cremer, P.C., Kumar, A., Kontzias, A., et al. Complicated pericarditis: understanding risk factors and pathophysiology to inform imaging and treatment. J Am Coll Cardiol 68 (2016), 2311–2328.
Donis, N., Oury, C., Moonen, M., et al. Treating cardiovascular complications of radiotherapy: a role for new pharmacotherapies. Expert Opin Pharmacother 19 (2018), 431–442.
Haydont, V., Bourgier, C., Pocard, M., et al. Pravastatin inhibits the Rho/CCN2/extracellular matrix cascade in human fibrosis explants and improves radiation-induced intestinal fibrosis in rats. Clin Cancer Res 13 (2007), 5331–5340.
van der Veen, S.J., Ghobadi, G., de Boer, R.A., et al. ACE inhibition attenuates radiation-induced cardiopulmonary damage. Radiother Oncol 114 (2015), 96–103.
Gurses, I., Ozeren, M., Serin, M., et al. Histopathological evaluation of melatonin as a protective agent in heart injury induced by radiation in a rat model. Pathol Res Pract 210 (2014), 863–871.
Gu, A., Jie, Y., Sun, L., et al. RhNRG-1beta protects the myocardium against irradiation-induced damage via the ErbB2-ERK-SIRT1 signaling pathway. PLoS One, 10, 2015, e0137337.
Guerrero, M., Urena, M., Himbert, D., et al. 1-Year outcomes of transcatheter mitral valve replacement in patients with severe mitral annular calcification. J Am Coll Cardiol 1 (2018), 1841–1853.
Saxena, P., Joyce, L.D., Daly, R.C., et al. Cardiac transplantation for radiation-induced cardiomyopathy: the Mayo Clinic experience. Ann Thorac Surg 98 (2014), 2115–2121.
Donnellan, E., Masri, A., Johnston, D.R., et al. Long-term outcomes of patients with mediastinal radiation-associated severe aortic stenosis and subsequent surgical aortic valve replacement: a matched cohort study. J Am Heart Assoc, 6, 2017, e005396.
Donnellan, E., Krishnaswamy, A., Hutt-Centeno, E., et al. Outcomes of patients with mediastinal radiation-associated severe aortic stenosis undergoing transcatheter aortic valve replacement. Circulation 138 (2018), 1752–1754.
Donnellan, E., Griffin, B.P., Johnston, D.R., et al. Rate of progression of aortic stenosis and its impact on outcomes in patients with radiation-associated cardiac disease: a matched cohort study. J Am Coll Cardiol Img 11 (2018), 1072–1080.
Neumann, F.J., Sousa-Uva, M., Ahlsson, A., et al. 2018 ESC/EACTS guidelines on myocardial revascularization. Eur Heart J 40 (2019), 87–165.
Baumgartner, H., Falk, V., Bax, J.J., et al. 2017 ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J 38 (2017), 2739–2791.
Fihn, S.D., Blankenship, J.C., Alexander, K.P., et al. 2014 ACC/AHA/AATS/PCNA/SCAI/STS focused update of the guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, and the American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 64 (2014), 1929–1949.
Windecker, S., Neumann, F.-J., Jüni, P., Sousa-Uva, M., Falk, V., Considerations for the choice between coronary artery bypass grafting and percutaneous coronary intervention as revascularization strategies in major categories of patients with stable multivessel coronary artery disease: an accompanying article of the task force of the 2018 ESC/EACTS guidelines on myocardial revascularization. Eur Heart J 40 (2019), 204–212.
Roffi, M., Patrono, C., Collet, J.P., et al. 2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). Eur Heart J 37 (2016), 267–315.
Reed, G.W., Masri, A., Griffin, B.P., et al. Long-term mortality in patients with radiation-associated coronary artery disease treated with percutaneous coronary intervention. Circ Cardiovasc Interv, 9, 2016, e003483.
Fender, E.A., Liang, J.J., Sio, T.T., et al. Percutaneous revascularization in patients treated with thoracic radiation for cancer. Am Heart J 187 (2017), 98–103.
Sio, T.T., Liang, J.J., Chang, K., et al. Dosimetric correlate of cardiac-specific survival among patients undergoing coronary artery stenting after thoracic radiotherapy for cancer. Am J Clin Oncol 40 (2017), 133–139.
Liang, J.J., Sio, T.T., Slusser, J.P., et al. Outcomes after percutaneous coronary intervention with stents in patients treated with thoracic external beam radiation for cancer. J Am Coll Cardiol Intv 7 (2014), 1412–1420.
Byrne, R.A., Serruys, P.W., Baumbach, A., et al. Report of a European Society of Cardiology-European Association of Percutaneous Cardiovascular Interventions task force on the evaluation of coronary stents in Europe: executive summary. Eur Heart J 36 (2015), 2608–2620.
Bonaa, K.H., Mannsverk, J., Wiseth, R., et al. Drug-eluting or bare-metal stents for coronary artery disease. N Engl J Med 375 (2016), 1242–1252.
Stone, G.W., Sabik, J.F., Serruys, P.W., et al. Everolimus-eluting stents or bypass surgery for left main coronary artery disease. N Engl J Med 375 (2016), 2223–2235.
Park, S.J., Ahn, J.M., Kim, Y.H., et al. Trial of everolimus-eluting stents or bypass surgery for coronary disease. N Engl J Med 372 (2015), 1204–1212.
Bangalore, S., Guo, Y., Samadashvili, Z., et al. Everolimus-eluting stents or bypass surgery for multivessel coronary disease. N Engl J Med 372 (2015), 1213–1222.
Valgimigli, M., Bueno, H., Byrne, R.A., et al. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: the Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 39 (2018), 213–260.
Levine, G.N., Bates, E.R., Bittl, J.A., et al. 2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 68 (2016), 1082–1115.
Mack, M.J., Leon, M.B., Thourani, V.H., et al. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med 380 (2019), 1695–1705.
Popma, J.J., Deeb, G.M., Yakubov, S.J., et al. Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients. N Engl J Med 380 (2019), 1706–1715.
Thourani, V.H., Forcillo, J., Szeto, W.Y., et al. Outcomes in 937 intermediate-risk patients undergoing surgical aortic valve replacement in PARTNER-2A. Ann Thorac Surg 05 (2018), 1322–1329.
Makkar, R.R., Jilaihawi, H., Mack, M., et al. Stratification of outcomes after transcatheter aortic valve replacement according to surgical inoperability for technical versus clinical reasons. J Am Coll Cardiol- 63 (2014), 901–911.
Siontis, G.C., Praz, F., Pilgrim, T., et al. Transcatheter aortic valve implantation vs. surgical aortic valve replacement for treatment of severe aortic stenosis: a meta-analysis of randomized trials. Eur Heart J 37 (2016), 3503–3512.
Yoon, S.H., Whisenant, B.K., Bleiziffer, S., et al. Outcomes of transcatheter mitral valve replacement for degenerated bioprostheses, failed annuloplasty rings, and mitral annular calcification. Eur Heart J 40 (2019), 441–451.
Shah, S., Alashi, A., Pettersson, G.B., et al. Characteristics and longer-term outcomes of paravalvular leak after aortic and mitral valve surgery. J Thorac Cardiovasc Surg 157 (2019), 1785–1792.e1.